INOVIO to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

INOVIO (NASDAQ:INO), a biotechnology company focused on DNA medicines, announced that President and CEO Jacqueline Shea, Ph.D., will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022, starting at 7:00 AM ET. The conference will feature one-on-one meetings with registered investors and a webcast available on the INOVIO Investor Relations Events page, with replays accessible for 90 days post-event. INOVIO specializes in developing treatments for infectious diseases and cancer.

PLYMOUTH MEETING, Pa., Aug. 30, 2022 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious diseases and treat people with cancer and HPV-associated diseases, today announced that Jacqueline Shea, Ph.D., President and CEO, will present at the H.C. Wainwright 24^th Annual Global Investment Conference.

H.C. Wainwright 24^th Annual Global Investment Conference
Date: Monday, September 12, 2022
Time: Available on-demand starting at 7:00 AM ET

During the conference, Dr. Shea and members of INOVIO's management team will conduct one-on-one meetings with registered investors.

A webcast of the presentation will be available on the INOVIO Investor Relations Events page at https://ir.inovio.com/events-and-presentations/default.aspx. A replay of the webcast will be available for 90 days after the date of the presentation.

About INOVIO

INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from infectious diseases, cancer, and diseases associated with HPV. Our DNA medicines in development are delivered using our investigational proprietary smart device to produce immune responses against targeted pathogens and cancers. For more information, visit www.inovio.com.

Contacts

Investors & Media:
Gene Kim, (267) 589-9471, gene.kim@inovio.com
Thomas Hong, (267) 440-4298, thomas.hong@inovio.com

 

View original content:https://www.prnewswire.com/news-releases/inovio-to-present-at-the-hc-wainwright-24th-annual-global-investment-conference-301614323.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When is INOVIO's presentation at the H.C. Wainwright 24th Annual Global Investment Conference?

INOVIO will present on September 12, 2022, starting at 7:00 AM ET.

Who will represent INOVIO at the conference?

Jacqueline Shea, Ph.D., President and CEO of INOVIO, will present at the conference.

Where can I watch INOVIO's conference presentation?

The presentation will be available on the INOVIO Investor Relations Events page.

How long will the webcast of INOVIO's presentation be available?

The webcast will be available for 90 days after the presentation date.

What is the focus of INOVIO's biotechnology development?

INOVIO focuses on developing DNA medicines for infectious diseases and cancer.